Sun gets Taro investor support for buyout

Sun Pharmaceuticals has won new support in its year-long tussle to buy Israeli drugmaker Taro Pharmaceuticals--in the form of backing from major Taro shareholder Templeton Asset Management. Report

Suggested Articles

WuXi AppTec has appointed Celgene CAR-T program veteran David Chang to lead its cell and gene therapy CDMO, WuXi Advanced Therapies.

Maryland-based Emergent BioSolutions has won a $628 million contract with BARDA to manufacture targeted COVID-19 vaccine hopefuls.

About 76% remdesivir patients had at least one point of clinical improvement on a 7-point scale at day 11, versus 66% of patients on standard care.